Thanks to a new technology, the diagnosis of brain cancer undergoes a breakthrough. The credit goes to cancer diagnostics company and University of Strathclyde Dxcover spin-out company. The company has indeed launched the liquid biopsy Dxcover, which was also effective in the early days of cancer growth, at a smaller volume and earlier stage.
q
There Research was published in the scientific journal Cancers.
Brain cancer: here are the advantages of the Dxcover liquid biopsy
According to Cancer Research UK, a 12,000 people in Britain are diagnosed with brain cancer each year and survival rates are 12% five years after diagnosis.
Read Also
- Will Leclerc hunt down Verstappen at home in an unexpected World Cup? May 28, 2022
- Control your smartphone with your PC : the application “Your phone” acquires a new interesting function Jun 8, 2020
- The diplomat detained in St. Petersburg arrives at the Estonian consulate Jul 8, 2021
- Backlash over Chime account closings highlights risks in fraud detection Jul 7, 2021
- Streptococcus A: 16 children infected in Spain, two of them die Dec 8, 2022
- One evening in the square: so we are once again excited with the Azzurri Jul 1, 2021
- Woman stopped wearing clothes due to allergy to her own skin Aug 12, 2021